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Key points 
 Several methods to overcome the lack of information in health care databases on the date 
of beginning of pregnancy, or its duration, have been used in epidemiologic research. 
 These methods vary in complexity, data element requirements, limitations, and accuracy. 
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Beginning and duration of pregnancy in automated health care databases: review of 
estimation methods and validation results 
 
ABSTRACT  
Purpose 
To describe methods reported in the literature to estimate the beginning or duration of 
pregnancy in automated health care data, and to present results of validation exercises where 
available. 
Methods 
Papers reporting methods for determining the beginning or duration of pregnancy were 
identified based on Pubmed searches, by consulting investigators with expertise in the field and 
by reviewing conference abstracts and reference lists of relevant papers. From each paper or 
abstract, we extracted information to characterize the study population, data sources, and 
estimation algorithm. We then grouped these studies into categories reflecting their general 
methodological approach. 
Results 
Methods were classified into 5 categories: (1) methods that assign a uniform duration for all 
pregnancies, (2) methods that assign pregnancy duration based on preterm-delivery or health 
care related codes, or codes for other pregnancy outcomes, (3) methods based on the timing of 
prenatal care, (4) methods based on birth weight, and (5) methods that combine elements from 
2 and 3. Validation studies evaluating these methods used varied approaches, with results 
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generally reporting on the mistiming of the start of pregnancy, incorrect estimation of the 
duration of pregnancy or misclassification of drug exposure during pregnancy or early 
pregnancy.  
Conclusions 
In the absence of accurate information on the beginning or duration of pregnancy, several 
methods of varying complexity are available to estimate them. Validation studies have been 
performed for many of them and can serve as a guide for method selection for a particular 
study.   
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Beginning and duration of pregnancy in automated health care databases: review of 
estimation methods and validation results 
 
INTRODUCTION 
Research on medications and other exposures in pregnancy is critical for public health. As  
exposures and pregnancy outcomes in need of evaluation are often uncommon, automated 
databases may be the only data sources able to provide reasonably precise estimates of 
exposure prevalence or relative risks in a cost efficient and timely manner. This is because they 
collect information on the health care provided to large populations, and are readily available.  
 
These data sources also present challenges, 1-4 particularly regarding the accurate 
ascertainment of the beginning of pregnancy, which is needed to assess the gestational age at 
the time of exposure or other events. Further, there are specific periods when disruptions of 
the physiological processes in the development of the embryo, fetus or related structures may 
increase the risk of an adverse outcome. Identifying these periods requires the beginning of 
pregnancy be known. In addition, outcomes with definitions based on gestational age, such as 
preterm delivery or fetal growth, must also be evaluated with reference to the beginning of 
pregnancy.  
 
Information on the onset of pregnancy is usually absent from claims data and not always 
present in electronic medical record databases. 5 However, both types of automated data 
generally have information on delivery or birth dates, or proxies for them (e.g., delivery hospital 
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admission date). 6, 7 Some data sources can be linked to birth certificates (e.g., Kaiser 
Permanente, Tennessee Medicaid), delivery hospitalization records (e.g., British Columbia, 
Ontario, Quebec) or medical records to obtain information on the date of conception, date of 
last menstrual period, expected due date, or gestational age at birth. But there are situations in 
which the linkage is not possible, the information on the beginning or duration of pregnancy is 
not available in the linked data, or the public health need for results is pressing and data linkage 
processing times are too long. Then, methods to overcome the lack of information on the start 
or length of pregnancy must be implemented.  
 
In this paper, we review methods that have been used to determine the beginning of pregnancy 
or the first trimester, or to estimate the duration of pregnancy, as well as validation studies that 
have evaluated their accuracy.  
 
LITERATURE SEARCH AND GROUPING OF METHODS 
The description of methods used for estimating pregnancy onset or duration is generally not 
reflected in papers’ titles, abstracts or key words. For that reason, we did not conduct a 
systematic literature search to identify studies for inclusion in the present review. Instead, we 
conducted multiple Pubmed searches using varied strategies, consulted investigators with 
expertise in research on drug safety in pregnancy with automated databases, examined 
conference abstract books and reviewed the reference section in papers already identified as 
relevant for this review.  
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We grouped methods reflecting their general approach in: (1) methods that assign a uniform 
duration of pregnancy, (2) methods that assign pregnancy duration based on preterm-delivery 
or related codes, or codes for other pregnancy outcomes, (3) methods based on the timing of 
prenatal care, (4) methods based on birth weight, and (5) methods that combine elements from 
2 and 3.  
 
From each manuscript or abstract, we abstracted information to characterize the study 
population, data sources, and estimation algorithm, highlighting findings from the earliest 
paper we found that used each methodology or the one that provided the most detailed 
description. We describe the methods’ ease of implementation and note which pregnancies 
would be excluded and which would have their duration incorrectly estimated. Then we discuss 
which exposures and outcomes the methods would be incapable of addressing and other  
limitations. Common themes are discussed at the end. Results from validation studies are 
presented in the online supplementary material. The online supplementary material also 
contains expanded information on each method. 
 
DESCRIPTION OF METHODS, STRENGTHS AND LIMITATIONS 
Methods, and their strengths and limitations, are summarized in Table 1 and the text below. 
While some methods estimated a start date, others estimated the duration of pregnancy (the 
beginning of pregnancy can be back-calculated from the pregnancy end date). Validation 
studies evaluating each method also used varied approaches. Results generally report on the 
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mistiming of the start of pregnancy, misclassification of drug exposure in pregnancy or early 
pregnancy, or incorrect estimation of the duration of pregnancy. 
 
1. Methods that assign a uniform duration of pregnancy 
 
These methods only require information on the pregnancy end date and are the easiest to 
implement: the beginning of pregnancy is estimated by subtracting the estimated duration of 
pregnancy from the pregnancy end date (e.g., date of delivery or proxies such as date of 
delivery hospital admission) in all pregnancies (Table 1 and Supplementary Table 1). The 
duration of pregnancy has generally been assumed to be between 270 and 280 days.  
 
The method’s main limitation is that the estimated pregnancy duration is several weeks too 
long in all preterm 8 and early term deliveries and a few days to weeks too short in all late term 
and post-term deliveries. Since many outcomes of interest are associated with a shorter 
pregnancy (e.g., some congenital malformations, preeclampsia), the duration of pregnancy 
might be incorrectly estimated among those pregnancies with the outcome. Consequently, 
gestational exposures among cases might be differentially misclassified. As a consequence, 
relative risk estimates for these outcomes can be biased toward or against the null. For 
example, for exposures that decrease after conception, cases would have an artificially high 
apparent prevalence of exposure in early pregnancy (Figure 1, top panel). 
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In response to this, pregnancies with an increased risk of preterm delivery (e.g., pregnancies 
with hypertension or cervical incompetence) can be analyzed separately 9 or excluded. 10, 11 This 
has important consequences: first, data from both mother and offspring are often needed to 
identify pregnancies at high risk of preterm delivery. Second, once these pregnancies have been 
excluded, the study population decreases in size and may no longer be representative of the 
overall population. Third, the distribution of exposures directly or indirectly associated 
(whether harmful or protective) with conditions selected for the identification of likely preterm 
pregnancies (e.g., drugs to treat hypertension, diabetes, or procedures to treat cervical 
incompetence) would be distorted in the study population. Moreover, preterm delivery and 
outcomes associated with preterm delivery cannot be studied using these methods.  
 
2. Methods that assign pregnancy duration based on preterm-delivery or related codes, or 
codes for other pregnancy outcomes 
 
Commonly used health care coding systems (e.g., International Classification of Diseases [ICD] 
9, ICD-10, Read codes) include codes for preterm delivery, preterm-related maternal or infant 
conditions, or use of related health care services. Codes may provide varying levels of detail, 
such as the relatively vague Read code Q11..11, “Baby born premature” or the more specific 
Read code 635B.00, “Baby premature 36 weeks”. Relevant information may reside in maternal 
or offspring, outpatient or inpatient data. The methods we present in this section use 
pregnancy-specific data to make pregnancy-specific estimations of pregnancy duration and are 
straight forward to apply (Table 1 and Supplementary Table 2). One method 12 assumed all 
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pregnancies with codes for miscarriage lasted 180 days, those with codes for preterm delivery 
lasted 210 days, etc. Another method 13 timed the conception window 252 to 287 days prior to 
delivery for singleton births, and 238 to 273 for births of multiple infants, and assumed a 4-
month long first trimester spanning from the earlier bound of the conception window to 91 
days after the later bound. Another method 14 used information on the date of the last 
menstrual period and gestational age at birth in codes and free text in electronic medical 
records when available. The remaining pregnancies were assumed to reach 280 days unless 
there was information on preterm delivery. Another study 8 created an indicator of preterm 
delivery using codes for short gestation or preterm labor and assigned pregnancies with the 
indicator a duration of 245 days and those without it, 273 days (these were the preferred 
durations based on validation results). Another method 15 used multiple codes for preterm-
related disorders, birth weight and post-natal care to create an indicator of delivery at 237 days 
(less than 34 completed weeks) or earlier. Another approach 16 assumed a duration of 
pregnancy equal to the upper limit of the range of gestational age at birth when the 
information was available in codes (e.g., ICD-9 code 765.28, “35-36 completed weeks of 
gestation”), 245 days for preterm-related codes with no gestational age specification, or 270 
days for the remaining pregnancies. An algorithm that incorporates ICD-9 codes for prolonged 
and post-term pregnancies has been proposed but, to our knowledge, has not yet been used. 17 
 
The ability to identify preterm deliveries avoids their exclusion from the study population and 
allows estimation of the duration of preterm pregnancies with less error than the methods 
previously described. Exposures and outcomes related to preterm delivery can thus be studied. 
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Still, with some of the methods, the earliest deliveries would be assigned too long a pregnancy 
duration. Post-term deliveries have most often been grouped with term deliveries. This is less 
of a concern, because post-term deliveries are generally not much longer than term 
pregnancies, as labor is typically induced at 41 or 42 completed weeks. 18  
 
3. Methods based on timing of prenatal health care 
 
Three approaches made use of information from prenatal health services utilization present in 
maternal records to make pregnancy-specific estimations (Table 1 and Supplementary Table 3). 
One study 19 used the date of the first booking, ambulatory or inpatient prenatal-care related 
code to define two time windows, one before and one after the code date. The first time 
window likely included the date of conception and the earliest weeks of pregnancy. The second 
window estimated the first trimester of pregnancy. Women with late initiation of prenatal care 
would have their two windows mistimed. Therefore, pregnancies with less than 7 months of 
prenatal care were excluded. Another study 8 assumed ambulatory prenatal screening tests 
that are recommended for a certain period of pregnancy (e.g., measurement of alpha 
fetoprotein, gestational weeks 11-14) are performed in the middle of the interval, and used the 
date of the test to estimate the date of the beginning of pregnancy. Information from multiple 
prenatal screening tests per pregnancy were combined through linear regression to obtain a 
single estimate of pregnancy duration for each pregnancy. Another study 20 used a similar 
approach but instead of combining the information from multiple tests per pregnancy, 
hierarchically selected a single prenatal test and based the duration estimate on it.  
 15 
 
 
These approaches rely on the assumption that pregnant women receive a recommended 
schedule of prenatal health care and will perform better in settings where prenatal care is 
available and highly standardized. Women with late initiation of prenatal care or who are 
screened outside the typical schedule for other reasons, however, would have their windows or 
their beginning of pregnancy mistimed. The first of these three methods 19 identified and 
excluded women who had a short prenatal follow-up. This exclusion reduced the study 
population and may specifically have depleted its shorter gestation higher risk pregnancies. If 
not excluded, pregnancies with late entry into the health care system would have had their 
conception date and first trimester estimated as too late. The second method 8 dealt with non-
standard prenatal care by only utilizing the first occurrence of each screening test in each 
pregnancy and making use of all patterns of prenatal care found in the study population, at the 
cost of a substantial complexity in the analysis.  
 
Limitations of the first method 19 include conception falling within some unknown distribution 
of time before the first pregnancy marker and the application of exclusion criteria that omit a 
sizeable proportion of the population. Its main strength is that it is very straight forward to 
apply. The main limitations of the second method 8 are the relatively intensive data 
management required, and the assumptions on the similarity of prenatal care between the 
study population in which the algorithm was developed and the population on which it would 
be applied. Its most important strength is its improved performance among preterm deliveries 
over other available methods. The third method 20 is easier to implement, but would similarly 
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depend on assumptions of comparable health care patterns. These three methods may be 
problematic in the study of exposures or outcomes related to non-standard care. For example, 
women who conceive using assisted reproductive technology may begin their health care very 
early and have earlier pregnancy markers than is typical. To accommodate this, the time 
windows used in the first method 19 could be redefined for earlier pregnancy markers. A 
remaining limitation is that diverse populations may access prenatal care differently, including 
groups at high risk for adverse outcomes.  
 
4. Method based on birth weight 
 
This method, 21 applied to pregnancies ending in a live or stillbirth with gestational age 
information at birth missing from birth certificates, is easy to implement (Table 1 and 
Supplementary Table 4). Using the race- and year-specific distribution of weight for gestational 
age at birth (derived from study pregnancies with complete data), this method assumes the 
birth weight is located on the median of the distribution and imputes the missing gestational 
age at birth with the value that corresponds to the recorded birth weight.  
 
A limitation of this method is that exposures or conditions that may affect growth (e.g., 
smoking, gestational diabetes) or outcomes related to growth or weight cannot be studied. For 
example, term infants small for their gestational age may be misclassified as preterm, possibly 
leading to differential misclassification of exposure (Figure 1, middle panel). Birth weight needs 
to be available, as well as summary statistics on birth weight for births of similar gestational 
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age, race and year of birth with known date of last menstrual period. Conceivably, the latter 
could be replaced with external data on a comparable population, if available.  
 
5. Methods that combine elements from #2 and #3 
 
One method 22 implemented a hierarchical algorithm that used information from hospital 
discharge records, laboratory tests, emergency department admissions and other data in a 
stepwise fashion to derive the pregnancy start date for each pregnancy (Table 1 and 
Supplementary Table 5). When none of this information was available, the algorithm resorted 
to national vital statistic figures for the median gestational age by outcome for seven outcome 
categories: very preterm live birth, preterm live birth, full-term live birth, spontaneous 
abortion, therapeutic abortion, stillbirth or ectopic pregnancy. In another study, 23 authors 
adapted the algorithm so that it would not require information from pregnancy laboratory 
tests. The adapted algorithm includes information from the health plan diagnosis, procedure, 
and birth files.   
 
An additional study 24 used a range of pregnancy related codes to determine the pregnancy 
duration in electronic medical records (algorithm details were presented in the poster 
associated with the referenced abstract). Codes were categorized and used in the following 
order of priority: a record for the estimated date of delivery, a record of the last menstrual 
period, gestational age time-related records (e.g. “A/N 20 week examination”, “Baby premature 
36 weeks”) and records relating to a preterm or post-term delivery which did not specify the 
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gestational age, which were set to a default duration of 36 weeks and 41 weeks respectively. 
For all remaining pregnancies a default pregnancy duration of 280 days for a delivery, including 
stillbirths, and 70 days for a pregnancy loss was assigned. A simplified version of this algorithm 
was used in a later publication .25 
 
The main advantage of these algorithms is that they make use of multiple sources of 
information. Imputing gestational age from national vital statistics ensures there will be no 
pregnancies whose duration is not estimable, as long as the pregnancy outcome is known and 
vital statistics for that outcome are available. Disadvantages include those discussed in the 
sections on methods that assign pregnancy duration based on preterm-delivery or related 
codes, and on methods based on timing of prenatal health care. 
 
DISCUSSION 
A number of methods to estimate the beginning or duration of pregnancy with satisfactory 
validation results have been proposed and used. It is reasonable to use all available and reliable 
information and minimize blanket imputations such as a fixed duration of pregnancy. The 
shorter the expected duration of exposure (e.g., an antibiotic therapy episode), the more 
important it is to obtain a precise (and correct) estimate of the pregnancy start date or 
duration. Chronic exposures are less vulnerable to misclassification 8, 16, 25, 26   than episodic 
exposures (mismeasurement of cumulative exposures may occur however, as shown in Figure 
1). Likewise, outcomes with a short risk period (e.g., congenital malformations) or that change 
quickly over pregnancy (e.g., gestational weight gain or fetal growth) warrant precise estimates. 
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Prenatal and postnatal care evolve and new screening tests and treatments become available. 
Estimation methods will need to be adapted to reflect current practices, which may differ 
across country, regions, facilities or health plans, and may vary over time in studies with a long 
study period. With current efforts to delay delivery until term or near term, methods that 
assume term pregnancy may be more precise for recent cohorts than for historical ones. Many 
of the methods described here require linkage of maternal and infants’ health care records, or 
maternal health care records and infants’ birth certificates to select the study population (e.g., 
to exclude preterm infants) or to extract other information needed for estimations. The linkage 
process may be complex and result in the loss of non-linkable potential study subjects, 
decreasing the study size. Further, if excluded subjects are not a random sample of the 
population, the study population may not be representative of the source population. 27 On the 
other hand, preterm delivery codes may be less accurate in studies that only use claims from 
maternal data than in studies that also use infant’s data. 28 
 
The list of papers, methods and validation results presented here (validation results are 
provided in the online supplementary material) is comprehensive but not necessarily 
exhaustive. We report detail to provide context to methods and validation results, but more 
information can be found in the original publications. The direction and amount of bias 
associated with the use of different estimation methods will vary depending on the study 
question and data characteristics. As mentioned, validation studies took very different 
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approaches, which limits the comparability of the results but provides a wide frame for the 
appreciation of methods´ caveats and strengths.  
 
Spontaneous or elective terminations, miscarriages and stillbirths 
 
Methods and validation results presented in this review are based on live births, with some 
exceptions.12, 21, 22, 24 Some methods could be generalized to pregnancies that were terminated 
or ended in a spontaneous abortion or a stillbirth. For example, a method based on the first 
record of prenatal care 19 could be used in such cases, as long as it is reasonable to assume that 
the initiation of prenatal care in those pregnancies has a comparable distribution to that 
described for term and close-to-term pregnancies.  
 
Conclusions 
In the absence of accurate information on the beginning or duration of pregnancy, several 
methods are available to estimate them. Methods vary in sophistication, information needed to 
implement them, and applications for which they are useful. While broad assignments of a 
fixed gestational age should be avoided, the most complex algorithms may not be optimal for a 
given study either. Validation results can serve as a guide in the selection of a method for a 
particular study.  
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Table 1. Summary of Methods 
Method Strengths Limitations Validated?  
1. Methods that assign a uniform 
duration of pregnancy 9-11, 29-34  
Easy to implement with limited data on mother 
and infant 
Estimated duration of pregnancy too long in 
preterm deliveries 
If preterm deliveries are excluded, distortion of 
distribution of preterm-related exposures and 
events may occur 
Estimated duration of pregnancy too short in post-
term deliveries 
Yes 6, 8, 26, 35 
2. Methods that assign pregnancy 
duration based on preterm-
delivery or related codes, or 
codes for other pregnancy 
outcomes 8, 12-16, 34, 36-38 
Exclusion of preterm births is avoided. 
Studies of exposures and outcomes related to 
preterm birth are feasible. 
Estimated duration of pregnancy too long in the 
earliest preterm deliveries  
Estimated duration of pregnancy too short in post-
term deliveries 
Yes 8, 15, 16 
3. Methods based on timing of 
prenatal health care 8, 19, 20 
Estimates are based on prospective prenatal care 
received by each pregnant woman 
Estimated duration of pregnancy possibly incorrect 
in pregnancies that receive non-standard health 
care  
Yes 8, 20, 26, 35 
4. Method based on birth weight 
21, 39-42 
 
Estimates are based on information from birth 
certificates, considered reliable 
Infants who  were born too large or too little for 
their gestational age and race would have their 
duration of gestation misestimated 
Summary information on birth weight by 
gestational age and race is required 
No 
5.Methods that combine 
elements of #2 and #3 20, 22-25, 43-45 
See #2 and #3 
 
See #2 and #3 Yes 22, 23 
Validation results and greater detail on methods are presented in the online supplementary material. 
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ONLINE SUPPLEMENTARY MATERIAL 
 
The first part of this online supplementary material presents selected validation results for each 
group of methods. The second part consists of 5 tables with expanded details on the methods 
and validation studies. 
 
PART I. Validation results 
1. Methods That Assign a Uniform Duration of Pregnancy 
In a validation study that assumed a duration of pregnancy of 270 days in all gestations, the 
authors compared results with the gold standard, (self-reported duration of pregnancy) and 
stratified analyses into preterm/term pregnancies. The sensitivity for exposure (antiinfective 
use in the first trimester) was 65.8% in preterm pregnancies and 92.5% in term gestations. 26 In 
another study, with an estimated gestational age at birth of 273 days, 8 the estimated beginning 
of pregnancy was within 2 weeks of the gold standard in 99.1% of the term pregnancies. 
However, 64% of preterm pregnancies had an estimate that was 2-4 weeks too early. In 4%, the 
estimate was more than 4 weeks too early. In relation to misclassification of exposure, 
compared to estimates based on the admission date as a proxy for delivery date and a 
pregnancy duration of 270 days, first-trimester drug use overall was 1.3% higher when the 
duration of pregnancy was estimated from the delivery date and the gestational age at birth 
information obtained from a birth registry. 6  
 
2. Methods That Assign Pregnancy Duration Based on Preterm-delivery or Related Codes, or Codes 
for Other Pregnancy Outcomes 
Two validation studies compared the pregnancy duration estimated with methods in this group 
to the pregnancy duration in discharge records for the delivery hospitalization or birth 
certificate files, stratified by preterm status. In one of them, the estimated and the recorded 
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duration of pregnancy were within 2 weeks of each other in 75% of preterm and 99% of term 
deliveries. 8 When looking at first-trimester use of medications, a chronic exposure (fluoxetine) 
based on algorithm-derived gestational age at birth had both sensitivity and positive predictive 
value (PPV) of 97%, and both specificity and negative predictive value (NPV) of 100%, relative to 
exposure timing determined from birth-certificate derived gestational age at birth. In the case 
of a shorter exposure (first-trimester use of amoxicillin), the sensitivity was 93%, PPV 92%, 
specificity and NPV 100%. 16 
 
3. Methods Based on Timing of Prenatal Health Care 
A validation study showed that, using the first of these methods, 77% of the initial study 
population met eligibility criteria related to duration of prenatal follow-up. In this group, the 
sensitivity of exposure (first-trimester use of antiinfectives) was 59%, and the specificity, 98%.  
26  In a validation study, the second method estimated the gestational age at birth within 2 
weeks of the gold standard from hospital discharge records in 75% of preterm deliveries, and in 
93% of term deliveries. Although this represents a marginal improvement for preterm deliveries 
over simpler methods based on the presence of preterm codes, this method has performed 
worse than simpler methods among term deliveries. 8 The third method has been reported to 
result in a mean difference of less than 1 day compared to birth-certificate gestational age and 
to be over 97% accurate in assigning first-trimester exposure to influenza vaccine. 20 
 
4. Method Based on Birth Weight 
No validation studies found. 
 
5. Methods That Combine Elements From #2 and #3 
In one study,22 81% of pregnancies matching on outcome date agreed on gestational age at 
birth within 2 weeks, and 13% agreed within 15-28 days. In the second study, 23 algorithm-
derived gestational ages were within 30 days of the corresponding gestational ages 
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documented in medical charts for 98% of live births, 83% of spontaneous abortions, 85% of 
therapeutic abortions, and 82% of other pregnancy outcomes.  
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PART II. Details of methods 
TABLE 1. Methods That Assign a Uniform Duration of Pregnancy 
Publication Study population Data source Estimation method Comments 
Publications 
which used 
related 
methods 
Grisso, 1994 10  Singleton pregnancies (maternal age 15; 
55 years old) with one or more inpatient 
delivery codes, one or more health-
related visits in the 9 months or more 
before delivery and a linked child in the 
database were eligible. One pregnancy 
per woman was retained. Each case of 
low-birth weight was matched with 4 
control pregnancies on maternal age at 
delivery and year of delivery. For 
subgroup analyses, pregnancies with 
codes for pregnancy complications 
within 270 days prior to delivery or 
codes for preterm delivery were 
excluded. 
1982-1987 
 
Health care 
claims from 
Medicaid from 
a single state, 
USA 
The duration of pregnancy was 
assumed to be 40 weeks. Gestational 
weeks and trimesters were back 
calculated from delivery. 
40 weeks was the window 
selected for exposure 
assessment. For the purpose of 
subgroup analyses, codes for 
pregnancy complications were 
searched for in the 270 days 
prior to delivery. 
Grisso,  
1997 30 
Jick, 1997 29  Women who delivered a liveborn and 
had entered the database at least 1 year 
before delivery. 
1988-1993 
 
Electronic 
medical 
records 
(GPRD), UK 
 
“The date of conception was 
calculated from gestational age and 
date of birth. If the gestational age 
was unknown, it was assumed to be 
280 days”. 
No description of the mother-
child matching process. 
Drinkard, 
2000 33 
Charlton, 
2008 32 
Andrade, 
2009 31 
Palmsten, 
2012 34 
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Andrade, 2004 9  Women who delivered an infant in a 
hospital with continuous enrollment and 
prescription drug coverage for at least 1 
year prior to delivery. Excluded those 
with no evidence of prenatal care within 
270 days of delivery (live births and 
stillbirths). 
 
1996-2000 
 
Health care 
claims from 8 
health 
managed 
organizations 
in 7 states, USA 
Pregnancy duration was assumed to 
be 270 days, with 3 90-day trimesters 
of pregnancy. The presence of 
diagnostic codes for conditions 
associated with preterm delivery 
(present in 15% of the deliveries) was 
used to stratify analyses. 
In a perinatal database 
maintained by one of the plans, 
the mean gestational length was 
273 days and the median was 
275 days.  
 
 
 
Andrade, 2006 11  Women who delivered an infant in a 
hospital with continuous enrollment and 
prescription drug coverage for at least 1 
year before delivery. Excluded those 
without evidence of prenatal care in the 
270 days prior to the delivery date. 
Retained only the first eligible delivery 
per woman. Pregnancies with diagnostic 
codes for conditions associated with a 
preterm delivery, or prescriptions for 
ovulation stimulants in the 270 
preceding delivery were excluded. 
1996-2000  
 
Health care 
claims from 8 
health 
managed 
organizations 
in 7 states, USA 
Pregnancies were assumed to have 
started 270 days prior to delivery 
date. 
For women who were included 
in the study and in a perinatal 
database maintained by one of 
the plans, the mean gestational 
length was 273 days and the 
median was 275 days.  
 
 
 
Validation studies 
Publication Study population Data source Methods Results  
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Raebel, 2005 6 Claims-based dataset: Female members 
> 15 years old admitted to a contracting 
hospital for delivery, with continuous 
enrollment and prescription drug 
coverage in pregnancy.  
Registry-based dataset: Female 
members > 15 years old with 
prescription drug coverage in pregnancy 
identified in a related birth registry that 
records deliveries at ≥24 weeks of 
gestation in the health care system.   
1997-2000 
 
Health care 
claims from a 
single health 
care plan in a 
single state, 
USA 
In the claims-based dataset, 
pregnancies were assumed to have a 
duration of 270 days. The first 
trimester was defined as days 270 to 
181 before admission for delivery 
(proxy for the delivery date).  In the 
registry-based dataset, the first 
trimester was defined as the initial 90 
days of gestation calculated from the 
delivery date and registry-recorded 
gestational age at birth. The two 
datasets were compared. Proportions 
of drug use in the first trimester and in 
the last 60 days of pregnancy among 
women present in both datasets were 
calculated. 
Of 541 deliveries identified in one dataset only, in 
45% the reason was that the 270 day or the 
admission as a proxy for delivery assumption did 
not hold, often combined with enrollment- or 
coverage-related eligibility criteria. The 
difference in proportions of drug use (any drug, 
FDA pregnancy category D, or category X) at any 
time in pregnancy, in the first trimester of 
pregnancy, or in the last 60 days of pregnancy 
comparing both datasets ranged between 0.02% 
and 1.04%. The difference in proportions relative 
to the drug use observed in the claims-based 
dataset ranged between 1.28% and 13.67%.  
Toh, 2008 26 3177 infants without malformations and 
their mothers. 
 
1998-2006 
 
Slone 
Epidemiology 
Center Birth 
Defects Study, 
data from a 
single state 
 
This study replicated Andrade´s 
method 11 as closely as possible, 
excluding conditions associated with 
preterm delivery. The first trimester of 
pregnancy was defined as the first 90 
days of pregnancy starting from 270 
days prior to delivery. Exposure to 
antiinfectives in the first trimester was 
estimated and compared to the 
exposure to the same drugs using 
Slone Epidemiology Center’s 
information on the date of last 
menstrual period as the gold standard. 
Sensitivity and specificity of the 
estimated first-trimester exposure to 
antiinfectives were reported. 
From 3177 women in the data source, 1949 were 
eligible following Andrade´s study eligibility 
criteria. The sensitivity (95% CI) for first-trimester 
exposure to antiinfectives was 92.1% (87.6%; 
95.3%); the specificity was 99.5% (99.1%; 99.8%). 
When, instead of the original eligibility criteria, 
the 3177 women were included and stratified by 
term/preterm birth, the sensitivity for terms was 
92.5% (89.3%; 95.0%); for preterms, it was 65.8% 
(48.7%; 80.4%). Specificity remained above 97% 
in all analyses. a 
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Devine, 2008 35 b 417,946 live births 1987-2006 
 
Electronic 
medical 
records 
(GPRD), UK 
 
The date of last menstrual period was 
back calculated from 301,384 
expected delivery dates.  Those with 
high certainty (“sure” in the data field 
for expected delivery date certainty) 
or those with a date of last menstrual 
period close to the one in the 
additional clinical data were retained. 
Then, the date of last menstrual 
period was estimated as 280 days 
prior to the delivery date in all 
deliveries. 
52,073 physician-based dates of last menstrual 
period were identified and linked to 30,240 
estimated dates. The absolute mean difference 
(95% CI) between the physician-based and the 
estimated date of last menstrual period was 6.4 
days (6.3; 6.5). For deliveries with delivery date 
within 7 days of the expected delivery date, it 
was 3.7 days (3.7; 3.8); and, for the rest, 10.7 
(10.8; 10.8). c 
Margulis, 2013 8 Hospital live births in province’s 
perinatal database with 365+280 days of 
outpatient coverage prior to the delivery 
date and gestational age at birth 
between 20 and 44 completed weeks. 
1998-2007 
 
Health care 
claims from 
single payer 
province-run 
health care 
system, 
Canada 
The duration of pregnancy was 
estimated as 280, or 273 days, and 
compared to the clinical gestational 
age at birth (reference) in the delivery 
hospitalization discharge record. 
Results are reported stratified by 
gestational age at birth <37 (preterm 
deliveries) or ≥37 completed weeks 
(term deliveries) in hospital records. 
The estimated gestational age at birth was within 
2 weeks of the clinical gestational age at birth in 
0% of preterm deliveries for an estimated 
duration of pregnancy of 280 or 273 days; in term 
deliveries, the figures were 93.3% for an 
estimated duration of pregnancy of 280 days, and 
99.1% for an estimated duration of pregnancy of 
273 days. 
CI: confidence interval; FDA: US Food and Drug Administration; GPRD: General Practice Research Database (currently Clinical Practice Research 
Datalink, CPRD) 
Note that we provide examples of publications which used the methods presented rather than a full list 
a Results from sensitivity analyses with varying duration of exposure and on relative risks for hypothetical outcomes are also presented. 
b Abstract 
c Sic
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TABLE 2. Methods That Assign Pregnancy Duration Based on Preterm-delivery or Related Codes, or Codes for Other Pregnancy Outcomes 
Publication Study population Data source Estimation method Comments 
Publications 
which used 
related 
methods 
Alonso, 2005 12 Women aged < 50 years old with a 
multiple sclerosis diagnosis with ≥ 3 
years of continuous enrollment before 
the first symptoms of multiple sclerosis, 
and up to 10 matched controls with the 
same eligibility criteria except for the 
multiple sclerosis diagnosis. Matching 
was based on age, practice and date of 
joining the practice.  
1993-2000 
Electronic 
medical 
records 
(GPRD), UK 
The duration of pregnancy was 
assumed to be 270 days for term 
deliveries and stillbirths, 210 days for 
preterm deliveries, 180 days for 
miscarriages, and 120 days for induced 
abortions. 
The authors report that other 
realistic imputations of the 
duration of pregnancy yielded 
similar results (not shown). 
 
Cole, 2007 13 Women 12 - 49 years old dispensed 
antidepressants who had a live birth, 
with 1 year of continuous enrollment 
before their delivery date. 
 
1995-2004 
Health care 
claims from 
several health 
plans from 
several 
regions, US 
Conception window: Singleton births: 
287 days to 252 days before delivery. 
Birth of multiple infants: 273 days to 
238 days before delivery. Estimated 
first trimester:  from the earliest 
probable conception date to 91 days 
after the last probable conception 
date.  No mention of how multiple 
versus singleton pregnancies were 
identified. 
A sensitivity analysis in data 
from women whose date of last 
menstrual period was available 
was conducted; the original 
odds ratios were corrected for 
misclassification of the first 
trimester; estimates did not 
change (not shown). 
Cole,   
2007 36 
 
Petersen, 2011 14 Pregnancies in women who had a live 
birth and were registered with a general 
practice for at least 6 months before the 
beginning of pregnancy and were still 
registered at the time of delivery 
1992 -2006 
 
Electronic 
medical 
records (THIN), 
UK 
“The duration of pregnancy was 
determined from information on the 
gestational age for the baby at birth, 
the Read code entries for the last 
menstrual period, and associated free 
text. If this information was not 
available and if there was no 
information in the notes of a preterm 
birth, the length of the pregnancy was 
imputed as 280 days. This method was 
used for 31% of the pregnancies.” 
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Eworuke, 2012 15 Infants with continuous eligibility for fee-
for-service benefits from birth to the 
earliest of 3 months of age or death 
("live births delivered between 15 and 50 
weeks"), linked to birth or death 
certificates 
 
1999-2004 
Medicaid 
claims from 2 
states, USA 
Evaluated the sensitivity and PPV of 5-
digit ICD-9 codes within code 765 to 
identify gestational age at birth up to 
34 completed weeks.  
Also, used logistic regression with 
duration of pregnancy data from birth 
certificates as outcome, and 53 
parameters related to birth weight, 
neonatal disorders and post-natal care 
from claims within 3 months of birth 
to estimate a prematurity score for 
each infant. Prematurity was defined 
as gestational age at birth < 34 
completed weeks. Selected the score 
with PPV≥90% that minimized false 
positives and assessed accuracy of the 
score. Up to 5-digit ICD-9 codes 
required. Assumed all pregnancies 
with a score above the threshold had 
duration < 34 weeks. 
 
 
Margulis, 2013 8 Hospital live births in province’s 
perinatal database with 365+280 days of 
outpatient coverage prior to the delivery 
date and gestational age at birth 
between 20 and 44 completed weeks. 
1998-2007 
 
Health care 
claims from 
single payer 
province-run 
health care 
system, 
Canada 
Preterm deliveries were identified via 
a preterm status indicator (presence 
of claims with 3 or 4-digit ICD-9 or 10 
codes for disorders related to short 
gestation or early labor) in the first 60 
days after delivery. Infants with codes 
for preterm were assigned a duration 
of gestation of 245 days and those 
without were assigned 273 days. 
 
  
Palmsten, 
2012 34 
Palmsten, 
2012 37 
 
Li, 2013 16  Pregnancies that ended in a live birth in 
women aged 15-45 years, with 
gestational age in the linked birth 
certificate between 20 and 45 weeks and 
compatible with the infant’s birth 
weight. For drug exposure assessments, 
it was further required that women had 
continuous plan enrollment with 
pharmacy benefits from 100 days prior 
to pregnancy through delivery. 
2001-2007 
Health care 
claims from 
several health 
plans in several 
regions, USA 
Gestational age at birth was assigned 
as: the upper limit of code description 
in pregnancies with codes specifying 
gestational age at birth; 245 days in 
pregnancies with codes for preterm 
delivery with no specification of 
gestational age at birth; 270 days for 
the remaining pregnancies. 
Birth certificates had a last-
menstrual-period derived 
gestational age, and a clinical or 
obstetric estimate; the authors 
found the difference was small 
and used the last menstrual 
period estimate in their analysis. 
The validity of birth certificate 
data for some of this data 
source had been previously 
validated.  
Margulis, 
2013 38 
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Validation studies 
Publication Study population Data source Methods Results 
Eworuke, 2012 15 See above See above See above. 
The sensitivity of ICD-9 codes 765.21-
765.27 individually and overall, 
relative to delivery at gestational age  
up to 34 weeks, and the sensitivity, 
specificity and PPV for the prematurity 
score were estimated in each state. 
The sensitivity of individual codes 765.21-765.27 
ranged between 11.4% and 15.5% in Texas, and 
from 19.9% and 29.7% in Florida. The sensitivity 
of the codes overall was 12.5% in Texas and 
25.7% in Florida. 
 
The sensitivity of the prematurity score was 
46.8% in Texas and 52.6% in Florida; its 
specificity, 99.9% and 99.8%; and its PPV, 82.2% 
and 91.7%, respectively. 
Li, 2012 16 See above See above See above. 
Summary statistics of the estimated 
gestational age are contrasted to 
those of the gold standard gestational 
age at birth from birth certificates. 
Drug use was assessed from dispensed 
prescriptions, adding 14 days to the 
days of supply. The sensitivity, 
specificity, PPV and NPV of drug use 
are reported.a 
Based on the algorithm, the prevalence of 
preterm delivery was 8.4%, while based on birth 
certificate data it was 15.3%. 
 
Among preterm deliveries (based on birth 
certificate data), 77.1% had an estimated 
duration of pregnancy within 2 weeks of the 
clinical gestational age at birth. Among term 
deliveries, the figure was 77%.  
 
First trimester exposure to fluoxetine based on 
the algorithm-derived gestational at birth had 
sensitivity and PPV of 97%, and specificity and 
NPV of 100%. For amoxicillin, the sensitivity was 
93%, PPV 92%, specificity and NPV 100%. 
Margulis, 2013 8 See above See above See above. 
Sensitivity, specificity, PPV and NPV of 
the preterm status indicator are 
presented. Agreement of estimated 
duration of pregnancy and clinical 
gestational age at birth are reported 
stratified by gestational age at birth 
<37 (preterm deliveries) or ≥37 
completed weeks (term deliveries) in 
hospital records. 
The preterm status indicator had a prevalence of 
8.5%, compared to 6.9% from vital statistics for 
the province. The sensitivity was 91% (95% CI 
91%; 91%); the specificity, 98% (98% ; 98%); the 
PPV, 74%; and the NPV, 99%. 
 
Among preterm deliveries (defined based on 
hospital-discharge data), 74.8% had an estimated 
duration of pregnancy within 2 weeks of the 
clinical gestational age at birth. Among term 
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deliveries, the figure was 99.1%. Other 
assumptions were evaluated and showed lower 
percentages of agreement. 
CI: confidence interval; ICD: International Classification of Diseases; GPRD: General Practice Research Database (currently Clinical Practice 
Research Datalink, CPRD); NPV: negative predictive value; PPV: positive predictive value; THIN: The Health Improvement Network 
a  Results from several stratified analyses and from drug use in other pregnancy time windows are presented in the publication. 
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TABLE 3. Methods Based on Timing of Prenatal Health Care 
Publication Study population Data source Estimation method Comments 
Publications 
which used 
related 
methods 
Hardy, 2006 19 Mapped pregnancies 46 with ≤280 days 
between the earliest pregnancy marker 
(i.e., codes  indicative of an ongoing 
pregnancy)  and  the pregnancy outcome 
(e.g., code for live birth),  in women aged 
15-44 years, with ≥ 7 months of prenatal 
records, linked to infants with ≥ 2 infant 
records in the first year of life. One 
pregnancy and one infant per woman 
were retained. These pregnancies were 
considered term or close to term. 
1991-1999 
Electronic 
medical 
records 
(GPRD), UK 
The reference date was the date with 
a first indicator of pregnancy (visit, 
procedure, etc.). Two periods of 
exposure were assessed: 90 days 
before the reference date (intended to 
capture filled prescriptions for 
medications that were to be taken in 
the first trimester of pregnancy, or 
medications that would remain in the 
body early in pregnancy; it likely 
included the date of conception and 
the earliest weeks of pregnancy), and 
70 days after the reference date 
(representing the first trimester).  
 Identification 
of early 
pregnancy 
markers:  
 
Piper, 1990 47  
Manson,  
2001 5  
Hardy,  
2004 46  
Devine,  
2010 48 
Kharbanda,  
2012 20 
Uncomplicated live births with birth 
certificate data in women enrolled in the 
Vaccine Safety Datalink. 
2002-2010 
 
Health care 
claims from 
several 
managed care 
organizations, 
USA 
Pregnancies were hierarchically 
assigned a duration of pregnancy 
based on the presence of codes for 5 
common prenatal tests and their 
assumed gestational timing. 
20% of the pregnancies did not 
have such codes; it is not clear 
how these pregnancies were 
handled. The population on 
which the algorithm was 
developed and validated is not 
described in detail in this 
publication. 
 
Margulis, 2013 8 Hospital live births in province’s 
perinatal database with 365+280 days of 
outpatient coverage prior to the delivery 
date and gestational age at birth 
between 20 and 44 completed weeks. 
1998-2007 
 
Health care 
claims from 
single payer 
province-run 
health care 
system, 
Canada 
Preterm deliveries were identified via 
a preterm status indicator. Within 
preterm and term deliveries as 
determined by the presence of the 
preterm status indicator, separately, 
linear regression was used to estimate 
the gestational age at birth based on 
the timing of prenatal screening tests.  
Hospital records were needed to 
estimate coefficients; not 
needed if coefficients were 
applied to other populations 
 
 40 
 
Validation studies 
Publication Study population Data source Methods Results  
Toh, 2008 26 3177 infants without malformations and 
their mothers   
 
1998-2006 
 
Slone 
Epidemiology 
Center Birth 
Defects Study, 
data from a 
single state, 
USA 
 
This study replicated Hardy’s 19 
method. Exposure to antiinfectives in 
the first trimester (i.e., the first 70 
days after the first prenatal visit) was 
estimated and compared to the 
exposure to the same drugs using 
Slone Epidemiology Center’s 
information as the gold standard. 
Sensitivity and specificity of the 
estimated first-trimester exposure to 
antiinfectives were reported.  
From 3177 women in the data source, 2447 were 
eligible following Hardy et al. eligibility criteria. 
The sensitivity (95% CI) for first-trimester 
exposure to antiinfectives was 59.1% (53.3%; 
64.5%); the specificity was 98.1% (97.5%; 98.7%). 
When, instead of the original eligibility criteria, 
the 3177 women were included and stratified by 
term/preterm birth, the sensitivity for terms was 
56.5% (51.1%; 61.7%); for preterms, it was 55.3% 
(38.3%; 71.4%). Specificity remained above 97% 
in all analyses. 
Devine, 2008 35 a  417,946 live births 1987-2006 
 
Electronic 
medical 
records 
(GPRD), UK 
 
The date of last menstrual period was 
back calculated from 301,384 
expected delivery dates. Pregnancies 
that had the expected delivery date 
estimated with high certainty (“sure” 
in the data field for expected delivery 
date certainty) or that had a date of 
last menstrual period close to the one 
in the additional clinical data were 
retained. Then the date of last 
menstrual period was estimated as 60, 
50, 40 and 30 days prior to the first 
marker of pregnancy care for all 
deliveries. 
52,073 physician-based dates of last menstrual 
period were identified and linked to 30,240 
estimated dates. The absolute mean difference 
between the physician-based and the estimated 
date of last menstrual period was 16.0 days (95% 
CI 15.8; 16.1), 11.8 (11.7; 12.0), 12.7 (12.5; 12.9), 
and 20.0 (19.7; 20.2), for the 60, 50, 40, and 30 
day estimations, respectively. 
Kharbanda,  
2012 20 
See above See above The algorithm was validated with a 
sample of women from a single site. 
The validation methods are not 
described. 
The mean (90% CI) for the difference in days 
between the estimated gestational age and the 
birth certificate’s was 0.92 (0.5; 1.4). “>97% 
accurate in assigning vaccination exposure by 
trimester”; accuracy is not defined.  
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Margulis, 2013 8 See above See above See above. 
Agreement of estimated duration of 
pregnancy and clinical gestational age 
at birth are reported stratified by 
gestational age at birth <37 (preterm 
deliveries) or ≥37 completed weeks 
(term deliveries) in hospital records. 
Among preterm deliveries, 75.8% had an 
estimated duration of pregnancy within 2 weeks 
of the clinical gestational age at birth. Among 
term deliveries, the figure was 93.9%. Other 
methods based on visits for prenatal screening 
were evaluated and showed lower percentages 
of agreement. 
CI: confidence interval; GPRD: General Practice Research Database (currently Clinical Practice Research Datalink, CPRD) 
 a Abstract 
TABLE 4. Method Based on Birth Weight 
 
Publication Study population Data source Estimation method Comments 
Publications 
which used 
related 
methods 
Piper, 1994 21  White or black women who delivered a 
single live infant with a recorded birth 
weight of 500 to 6000 grams or a 
stillborn infant. Excluded women 
enrolled before the start of the index 
pregnancy. 1-2% of birth and fetal death 
certificates were excluded because of 
missing data. 
 
1988-1989 
Health care 
claims from 
Medicaid from 
a single state, 
USA 
The date of last menstrual period from 
the birth or death certificate was 
considered the beginning of 
pregnancy. If only month and year 
were available, the date of last 
menstrual period was imputed as the 
15th day of the month. For deliveries 
with missing month or year, or live 
births with duration of pregnancy 
<140 or >294 days (15%), it was 
estimated as the median duration of 
pregnancy for infants of similar race 
and birth weight. 
Requires availability of summary 
information on birth weight by 
gestational age at birth and race. 
Piper, 1987 40 
Ray,  
1998 41  
Cooper,  
2006 42    
Cooper,  
2007 39  
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TABLE 5. Methods That Combine Elements From #2 and #3 
Publication Study population Data source Estimation method Comments 
Publications 
which used 
related 
methods 
Hornbrook,  
2007 22  
Among 251,251 women 12-55 years old 
enrolled for at least 42 days in the study 
period, pregnancy episodes were 
identified from diagnosis (ICD-9), 
procedure, imaging, laboratory and 
pharmacy claims. Pregnancies were 
retained if the entire pregnancy took 
place within the study period and the 
woman was enrolled at the time of the 
pregnancy outcome (24,680 pregnancies 
in 21,001 women). Pregnancy outcomes 
included were: ectopic pregnancies, 
spontaneous abortions, therapeutic 
abortions, very preterm live birth, 
stillbirth, preterm live birth, term live 
birth. 
1998-2001 
Health care 
claims from a 
single 
managed care 
organization,  
USA 
Pregnancy outcomes and their dates 
were identified. Then, a hierarchical 
algorithm was applied to estimate the 
date of the beginning or pregnancy. 
Preference for estimation of the 
gestational age at pregnancy end was 
given in this order: gestational age in 
the hospital discharge record, 
gestational age in alpha fetoprotein 
test, 40 weeks for pregnancies in the 
Preterm Birth Prevention Program 
database, gestational age from 
emergency department admission 
date, gestational age at outcome from 
national median figures. 
 Kharbanda 
2012 20 
Naleway, 
2013 23 
 
Snowball,  
2007 24 a 
Among 2,186,366 women considered 
valid members of GPRD aged 11 to 49, 
pregnancies were identified based on 
codes related to antenatal, neonatal and 
postnatal care, pregnancy, birth and 
termination. Pregnancy outcomes 
(deliveries and terminations) and their 
dates were identified (494,449 
pregnancies  of which 359,712 had 
delivery for outcome).  
1992-2006 
 
Electronic 
medical 
records 
(GPRD), UK 
A hierarchical algorithm assigned 
pregnancy duration based on  (in this 
order) a  record of the estimated due 
date, a record of the first day of the 
last menstrual period, a code 
specifying gestational age (e.g., “baby 
premature 36 weeks”), or a code 
specifying pre or post-term delivery 
without reference to a specific 
gestational age (defaults values were 
36 and 41 weeks, respectively).  
Pregnancies without any of the above 
were assigned a default duration of 40 
weeks for deliveries, or 10 weeks for 
terminations. 
 Charlton, 
2011 25 
Sammon, 
2012 45 
Ban, 2012 43 
Charlton, 
2013 44 
Validation studies 
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Publication Study population Data source Methods Results  
Hornbrook,  
2007 22 
See above See above. The 
validation 
sample 
included 511 
women; 
pregnancies 
were randomly 
selected for 
validation 
within 
pregnancy  
outcome strata 
(678 
pregnancies) 
Information abstracted from medical 
charts: presence of a pregnancy, 
pregnancy outcome, and pregnancy 
outcome and beginning dates. 
Agreement for outcome dates was 
considered present when the 
algorithm and medical chart outcome 
dates were within 30 days of each 
other. Among those with agreement, 
gestational age agreement within 2 
weeks and 15-28 days was estimated. 
94% of pregnancies (640/678) agreed on the 
outcome date. 81% of the 640 pregnancies 
agreed on gestational age at birth within 2 
weeks, and 13% agreed within 15-28 days. 
Agreement by pregnancy outcome and other 
stratified results are presented in the original 
publication. 
Naleway, 2013 23 For the validation study, 420 pregnancies 
enrolled in the Vaccine Safety Datalink 
were sampled (15 pregnancies ending in: 
live birth, spontaneous abortion, elective 
or therapeutic abortion, and other 
pregnancy outcomes). Eligible 
pregnancies were those ending in 2002-
2006 in women 12-55 years old 
continuously enrolled from 3 months 
prior to pregnancy through 1 month 
after the end of pregnancy. A single 
pregnancy per woman was retained. 
2002-2006 
 
Electronic 
medical 
records, health 
care claims and 
other sources 
from several 
health care 
plans, USA 
Hornbrook’s algorithm was adapted 
for use with the information available 
in the data source (laboratory tests, 
pharmacy dispensing and imaging 
procedures were not available).  
Agreement for pregnancy end date 
and for gestational age at the end of 
pregnancy was considered present 
when the algorithm- and the medical-
chart-derived numbers were within 30 
days of each other. 
 
In 67% of all pregnancies, there was an exact 
match between the algorithm and the medical 
chart pregnancy end dates; in 84% of 
pregnancies, end dates from the two sources 
were within 14 days of each other. 
 
Among pregnancies ending in live births, 
agreement on the pregnancy end date was 
present in 96% of the pregnancies; agreement on 
gestational age at birth was present in 98% of the 
subset with recorded gestational age at birth in 
the chart. Among pregnancies ending in 
spontaneous abortions, the figures were 95% and 
83%, respectively. Among pregnancies ending in 
therapeutic abortion, the figures were 70% and 
85%, respectively. Among pregnancies ending in 
other outcomes, figures were 85% and 82%, 
respectively. 
a The algorithm described here was presented in detail in the associated poster at the 2007 International Conference on Pharmacoepidemiology 
and Therapeutic Risk Management. 
 
